
    
      This is an observational, prospective non-interventional study of participants with GERD.
      This study will evaluate the effect of dexlansoprazole treatment among participants with
      GERD.

      The study will enroll approximately 1500 participants. Due to non-interventional design of
      the study, the decision about GERD treatment strategy for the participant is taken by
      attending treating physician. All participants will be enrolled in one observational group:
      dexlansoprazole.

      Prospective data will be collected for a period of 2 months. The frequency of the visits will
      be assigned by each physician according to their routine practice.

      The multi-center trial will be conducted in Russia. The overall duration of study will be
      approximately 2 months.
    
  